Development of pemphigus vulgaris after the second dose of the mRNA‐1273 SARS‐Cov‐2 vaccine

Saved in:
Bibliographic Details
Published inOral diseases Vol. 28; no. S2; pp. 2612 - 2613
Main Authors Koutlas, Ioannis G., Camara, Renee, Argyris, Prokopios P., Davis, Mark Denis P., Miller, Daniel D.
Format Journal Article
LanguageEnglish
Published Malden Wiley Subscription Services, Inc 01.11.2022
Subjects
Autoimmune diseases
mRNA
Pemphigus
Severe acute respiratory syndrome coronavirus 2
Skin diseases
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:1354-523X
1601-0825
DOI:10.1111/odi.14089